Guidelines on Hematuria: Urologic and Nephrologic Evaluation

The American Urological Association (AUA) published guidelines for asymptomatic microhematuria. The document includes 19 guidelines with recommendation levels ranging from A to C (high to low) and some expert opinion recommendations included. The full guidelines can be accessed at  http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf.

Q: I have a 58-year-old female patient who is taking warfarin for atrial fibrillation and is complaining about blood in her urine. She is postmenopausal, so I think it is just the warfarin. Other than checking her international normalized ratio (INR), what else should I be doing?

In addition to checking an INR, it is important to investigate benign causes for the hematuria. Asymptomatic hematuria requires obtaining a thorough history, which includes common risk factors for urinary tract malignancy, physical exam, and laboratory evaluation. Initially, a noncontaminated urinalysis with culture and sensitivity should be obtained to rule out infection.

If a benign cause cannot be found in any patient undergoing anticoagulation therapy, the AUA (guideline 6)¹ recommends a urologic and nephrologic evaluation. Anticoagulation therapy would include all anticoagulant and antiplatelet agents, such as aspirin, Plavix (clopidogrel), Pletal (cilostazol), Coumadin (warfarin), heparin, or heparin derivatives, such as Lovenox (enoxaparin).

The urologic evaluation may include urology referral, cystoscopy for patients 35 or older, and multiphasic CT urography, performed with and without contrast. A nephrologic evaluation would initially include a urinalysis, calculated eGFR, creatinine, and BUN, and a nephrology referral when indicated. A thorough evaluation is indicated for all patients with hematuria who are on anticoagulant therapy to ensure that a urinary tract malignancy is not present.

AUA guidelines 10 through 13¹ address alternative tests for patients with kidney disease in whom contrast dye is contraindicated.

Kristy Washinger, MSN, CRNP, Nephrology Associates of Central Pennsylvania, Camp Hill, PA

References
1. Davis R, Jones JS, Barocas DA, et al; American Urological Association. Diagnosis, Evaluation, and Follow-up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. Linthicum, MD: American Urological Association Education and Research, Inc; 2012.  http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf. Accessed January 24, 2013.
2. National Kidney and Urologic Diseases Information Clearinghouse. Hematuria: blood in the urine (2012). http://kidney.niddk.nih.gov/kudiseases/pubs/hematuria. Accessed January 17, 2013.
3. Geavlete B, Jecu M, Multescu R, et al. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer: re-TURBT recurrence rates in a prospective, randomized study. Urology. 2010;76(3):664-669.

Suggested Reading
Feldman AS, Hsu C-Y, Kurtz M, Cho KC. Etiology and evaluation of hematuria in adults (2012). www.uptodate.com/contents/etiology-and-evaluation-of-hematuria-in-adults. Accessed January 17, 2013.
Jayne D. Hematuria and proteinuria. In: Greenberg A, ed; National Kidney Foundation. Primer on Kidney Diseases. 5th ed. Saunders; 2009:33-42.

The American Urological Association (AUA) published guidelines for asymptomatic microhematuria. The document includes 19 guidelines with recommendation levels ranging from A to C (high to low) and some expert opinion recommendations included. The full guidelines can be accessed at  http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf.

Q: I have a 58-year-old female patient who is taking warfarin for atrial fibrillation and is complaining about blood in her urine. She is postmenopausal, so I think it is just the warfarin. Other than checking her international normalized ratio (INR), what else should I be doing?

In addition to checking an INR, it is important to investigate benign causes for the hematuria. Asymptomatic hematuria requires obtaining a thorough history, which includes common risk factors for urinary tract malignancy, physical exam, and laboratory evaluation. Initially, a noncontaminated urinalysis with culture and sensitivity should be obtained to rule out infection.

If a benign cause cannot be found in any patient undergoing anticoagulation therapy, the AUA (guideline 6)¹ recommends a urologic and nephrologic evaluation. Anticoagulation therapy would include all anticoagulant and antiplatelet agents, such as aspirin, Plavix (clopidogrel), Pletal (cilostazol), Coumadin (warfarin), heparin, or heparin derivatives, such as Lovenox (enoxaparin).

The urologic evaluation may include urology referral, cystoscopy for patients 35 or older, and multiphasic CT urography, performed with and without contrast. A nephrologic evaluation would initially include a urinalysis, calculated eGFR, creatinine, and BUN, and a nephrology referral when indicated. A thorough evaluation is indicated for all patients with hematuria who are on anticoagulant therapy to ensure that a urinary tract malignancy is not present.

AUA guidelines 10 through 13¹ address alternative tests for patients with kidney disease in whom contrast dye is contraindicated.

Kristy Washinger, MSN, CRNP, Nephrology Associates of Central Pennsylvania, Camp Hill, PA

References
1. Davis R, Jones JS, Barocas DA, et al; American Urological Association. Diagnosis, Evaluation, and Follow-up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. Linthicum, MD: American Urological Association Education and Research, Inc; 2012.  http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf. Accessed January 24, 2013.
2. National Kidney and Urologic Diseases Information Clearinghouse. Hematuria: blood in the urine (2012). http://kidney.niddk.nih.gov/kudiseases/pubs/hematuria. Accessed January 17, 2013.
3. Geavlete B, Jecu M, Multescu R, et al. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer: re-TURBT recurrence rates in a prospective, randomized study. Urology. 2010;76(3):664-669.

Suggested Reading
Feldman AS, Hsu C-Y, Kurtz M, Cho KC. Etiology and evaluation of hematuria in adults (2012). www.uptodate.com/contents/etiology-and-evaluation-of-hematuria-in-adults. Accessed January 17, 2013.
Jayne D. Hematuria and proteinuria. In: Greenberg A, ed; National Kidney Foundation. Primer on Kidney Diseases. 5th ed. Saunders; 2009:33-42.

The American Urological Association (AUA) published guidelines for asymptomatic microhematuria. The document includes 19 guidelines with recommendation levels ranging from A to C (high to low) and some expert opinion recommendations included. The full guidelines can be accessed at  http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf.

Q: I have a 58-year-old female patient who is taking warfarin for atrial fibrillation and is complaining about blood in her urine. She is postmenopausal, so I think it is just the warfarin. Other than checking her international normalized ratio (INR), what else should I be doing?

In addition to checking an INR, it is important to investigate benign causes for the hematuria. Asymptomatic hematuria requires obtaining a thorough history, which includes common risk factors for urinary tract malignancy, physical exam, and laboratory evaluation. Initially, a noncontaminated urinalysis with culture and sensitivity should be obtained to rule out infection.

If a benign cause cannot be found in any patient undergoing anticoagulation therapy, the AUA (guideline 6)¹ recommends a urologic and nephrologic evaluation. Anticoagulation therapy would include all anticoagulant and antiplatelet agents, such as aspirin, Plavix (clopidogrel), Pletal (cilostazol), Coumadin (warfarin), heparin, or heparin derivatives, such as Lovenox (enoxaparin).

The urologic evaluation may include urology referral, cystoscopy for patients 35 or older, and multiphasic CT urography, performed with and without contrast. A nephrologic evaluation would initially include a urinalysis, calculated eGFR, creatinine, and BUN, and a nephrology referral when indicated. A thorough evaluation is indicated for all patients with hematuria who are on anticoagulant therapy to ensure that a urinary tract malignancy is not present.

AUA guidelines 10 through 13¹ address alternative tests for patients with kidney disease in whom contrast dye is contraindicated.

Kristy Washinger, MSN, CRNP, Nephrology Associates of Central Pennsylvania, Camp Hill, PA

References
1. Davis R, Jones JS, Barocas DA, et al; American Urological Association. Diagnosis, Evaluation, and Follow-up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. Linthicum, MD: American Urological Association Education and Research, Inc; 2012.  http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf. Accessed January 24, 2013.
2. National Kidney and Urologic Diseases Information Clearinghouse. Hematuria: blood in the urine (2012). http://kidney.niddk.nih.gov/kudiseases/pubs/hematuria. Accessed January 17, 2013.
3. Geavlete B, Jecu M, Multescu R, et al. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer: re-TURBT recurrence rates in a prospective, randomized study. Urology. 2010;76(3):664-669.

Suggested Reading
Feldman AS, Hsu C-Y, Kurtz M, Cho KC. Etiology and evaluation of hematuria in adults (2012). www.uptodate.com/contents/etiology-and-evaluation-of-hematuria-in-adults. Accessed January 17, 2013.
Jayne D. Hematuria and proteinuria. In: Greenberg A, ed; National Kidney Foundation. Primer on Kidney Diseases. 5th ed. Saunders; 2009:33-42.